Cargando…

Less basal thyrotropin levels predict antidepressant response in patients with major depression

INTRODUCTION: The close association among thyroid metabolism, mood disorders and behavior has long been known. The role of basal thyroid axis in antidepressant treatment response is less known. OBJECTIVES: The aim of the present study was to study the association of basal serum thyrotropin (TSH) lev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Navinés, R., Oriolo, G., Mora, M., Cavero, M., Gómez-Gil, E., Martin-Santos, R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2022
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9565975/ http://dx.doi.org/10.1192/j.eurpsy.2022.662

Ejemplares similares

High S100B Levels Predict Antidepressant Response in Patients With Major Depression Even When Considering Inflammatory and Metabolic Markers
por: Navinés, Ricard, et al.
Publicado: (2022)

The effect of antidepressant treatment on white matter integrity in Major Depression
por: Tourjman, S., et al.
Publicado: (2022)

PS97. Serum Cytokine Levels in Major Depressive Disorder and Its Role in Antidepressant Response
por: Myung, Woojae, et al.
Publicado: (2016)

Potential of antithrombin III as a biomarker of antidepressive effect in major depressive disorder
por: Song, R., et al.
Publicado: (2021)

Effectiveness of antidepressants in bipolar depression
por: Potanin, S., et al.
Publicado: (2021)

PS82. Does Serum Amyloid ß-Protein predict the Response to Antidepressant treatment in Major Depression?
por: Inoue, Megumi, et al.
Publicado: (2016)

PS129. Low TNFAIP3 was normalized with antidepressant in patients with major depressive disorder
por: Hung, Yi-Yung
Publicado: (2016)

PS188. Predict value of functional topological features for early response to antidepressant treatment in major depressive disorder
por: Hou, Zhenghua, et al.
Publicado: (2016)

Glucocorticoid Receptors, Brain-Derived Neurotrophic Factor, Serotonin and Dopamine Neurotransmission are Associated with Interferon-Induced Depression
por: Udina, M, et al.
Publicado: (2015)

Longitudinal effects of antidepressant treatment on resting state functional connectivity in adolescents with major depressive disorder
por: Lee, K.H., et al.
Publicado: (2022)

PS92. Serum BDNF and GDNF levels before and after the 12-week antidepressant treatments among outpatients with major depressive disorder
por: Lee, Bun-Hee, et al.
Publicado: (2016)

Incidence of depression in patients with hepatitis C treated with direct-acting antivirals
por: Egmond, Elfi, et al.
Publicado: (2019)

Vickybot, a chatbot for anxiety-depressive symptoms and work-related burnout
por: Anmella, G., et al.
Publicado: (2023)

PS76. Effect of antidepressant therapy on white matter in patients with first-episode major depressive disorder
por: Lee, Chun-Te, et al.
Publicado: (2016)

Early changes in brain structure, functional connectivity and neuropsychiatric symptoms after HCV infection cure with direct-acting antivirals
por: Cavero, M., et al.
Publicado: (2021)

Telomere length from peripheral blood DNA in major depressive disorder: a case/control comparison and association with antidepressant treatment response
por: Kalinovic, R., et al.
Publicado: (2023)

An electroencephalographic signature predicts antidepressant response in major depression
por: Wu, Wei, et al.
Publicado: (2020)

Pharmacogenetics to Personalize Dosing of Tricyclic Antidepressants in Major Depressive Disorder: A Randomized Clinical Trial (PITA study)
por: Ter Hark, S., et al.
Publicado: (2023)

The power of multimodal antidepressants: decrease of soluble ST2 blood level in patients with depression and comorbid heart failure
por: Sikora, A. K., et al.
Publicado: (2023)

Quantifying the level of difficulty to treat major depressive disorder with antidepressants: Treatment Resistance to Antidepressants Evaluation Scale
por: Liu, Tzu-Yu, et al.
Publicado: (2020)

PS78. Naturalistic, retrospective comparison between antidepressant therapy and atypical antipsychotic augmentation therapy for patients with major depressive disorder
por: Cho, Se Hoon, et al.
Publicado: (2016)

PS102. Apathy in elderly depression and the antidepressant response
por: Shimano, Takahisa, et al.
Publicado: (2016)

Major depressive disorder with anxious features - the role of pregabalin
por: Carvalho, R. S., et al.
Publicado: (2023)

Significant early and long-term improvement of neuropsychiatry symptomatology in HCV-infected patients after viral eradication with DAA
por: Martin-Santos, R., et al.
Publicado: (2022)

Vasopressin surrogate marker copeptin as a potential novel endocrine biomarker for antidepressant treatment response in major depression: A pilot study
por: Agorastos, A., et al.
Publicado: (2021)

Should antidepressants be used for major depressive disorder?
por: Jakobsen, Janus Christian, et al.
Publicado: (2020)

ARPNet: Antidepressant Response Prediction Network for Major Depressive Disorder
por: Chang, Buru, et al.
Publicado: (2019)

Serum Cytokine Levels in Major Depressive Disorder and Its Role in Antidepressant Response
por: Myung, Woojae, et al.
Publicado: (2016)

“Lactose free” depression- Antidepressant with and without lactose registered in Croatia
por: Svetinović, D., et al.
Publicado: (2023)

Less is more
por: Alayón, R., et al.
Publicado: (2022)

Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in elderly patients
por: Grembiale, A, et al.
Publicado: (2010)

Five Interpersonal Factors Are Predictive of the Response to Treatment of Major Depression With Antidepressants in Primary Care
por: Salazar-Fraile, José, et al.
Publicado: (2018)

Antidepressants in epilepsy
por: Gutiérrez Rodríguez, M.M., et al.
Publicado: (2022)

Brain aging in major depressive disorder
por: Han, L., et al.
Publicado: (2021)

PS180. Relationship between frontal lobe function and antidepressant treatment in bipolar disorder and major depressive disorder: a near-infrared spectroscopy study
por: Tomioka, Hiroi, et al.
Publicado: (2016)

Changes in the serum levels of inflammatory cytokines in antidepressant drug-naïve patients with major depression
por: Zou, Wei, et al.
Publicado: (2018)

Influence of antidepressants on plasma levels of nitric oxide metabolites in patients with major depressive disorder
por: Ikenouchi, Atsuko, et al.
Publicado: (2021)

The Roles of BDNF in the Pathophysiology of Major Depression and in Antidepressant Treatment
por: Lee, Bun-Hee, et al.
Publicado: (2010)

Brain Structural Effects of Antidepressant Treatment in Major Depression
por: Dusi, Nicola, et al.
Publicado: (2015)

Catatonia in a case of major depression resistant to pharmacotherapy. A case report
por: Gil Sánchez, C. M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_33d3ql4d301liis0io0ves2651